• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CONCENTRIC MEDICAL TREVO XP PROVUE RETRIEVER 4X30; CATHETER, THROMBUS RETRIEVER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CONCENTRIC MEDICAL TREVO XP PROVUE RETRIEVER 4X30; CATHETER, THROMBUS RETRIEVER Back to Search Results
Catalog Number 90185
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Embolus (1830)
Event Date 04/02/2017
Event Type  Injury  
Manufacturer Narrative
The subject device is not available.
 
Event Description
The patient underwent a thrombectomy procedure to restore blood flow to the right mca-m1 segment.Post procedure the patient achieve a tici score of 2b, and at 24 hours, a nihss of 38.Approximately 7 days post the index procedure, the patient was assessed having a nihss of 12 and a mrs of 4.The patient was discharged to another short term general hospital 10 days post the index procedure.Embolization to new territory (ent) was not observed by the study facility post procedure; however, further review performed by independent lab facility indicated that ent had occurred in the anterior cerebral artery (aca).No adverse events associated with the aca-ent were reported.No further information is available.
 
Manufacturer Narrative
Executive summary was updated to reflect additional information received on 10-oct-2017 indicating that the high nihss post recanalization was due to the fact that the patient was intubated therefore is not representative.After the extubation the patient's nihss score was 16.
 
Event Description
The patient underwent a thrombectomy procedure to restore blood flow to the right mca-m1 segment.Post procedure the patient achieve a tici score of 2b, and at 24 hours, a nihss of 38.The study facility reported that the high nihss post recanalization was due to the fact that the patient was intubated therefore is not representative.After the extubation, the patient's nihss score was 16 and approximately 7 days post the index procedure, the patient was assessed having a nihss of 12 and a modified ranquin scale (mrs) of 4.The patient was discharged to another short term general hospital 10 days post the index procedure.Embolization to new territory (ent) was not observed by the study facility post procedure; however, further review performed by independent lab facility indicated that ent had occurred in the anterior cerebral artery (aca).No adverse events associated with the aca-ent were reported.No further information is available.
 
Manufacturer Narrative
The device history record (dhr) review confirmed that the device met all material, assembly and performance specifications.The subject device remains implanted; therefore, physical as well as a functional evaluation could not be performed.However, embolus is a known risk associated with endovascular procedures and is noted as such in the device direction for use (dfu).Therefore, an assignable cause of anticipated procedural complications was assigned to this event.
 
Event Description
The patient underwent a thrombectomy procedure to restore blood flow to the right mca-m1 segment.Post procedure the patient achieve a tici score of 2b, and at 24 hours, a nihss of 38.The study facility reported that the high nihss post recanalization was due to the fact that the patient was intubated therefore is not representative.After the extubation, the patient's nihss score was 16 and approximately 7 days post the index procedure, the patient was assessed having a nihss of 12 and a modified ranquin scale (mrs) of 4.The patient was discharged to another short term general hospital 10 days post the index procedure.Embolization to new territory (ent) was not observed by the study facility post procedure; however, further review performed by independent lab facility indicated that ent had occurred in the anterior cerebral artery (aca).No adverse events associated with the aca-ent were reported.No further information is available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TREVO XP PROVUE RETRIEVER 4X30
Type of Device
CATHETER, THROMBUS RETRIEVER
Manufacturer (Section D)
CONCENTRIC MEDICAL
301 east evelyn
mountain view CA 94041
Manufacturer (Section G)
CONCENTRIC MEDICAL
301 east evelyn
mountain view CA 94041
Manufacturer Contact
tara lopez
301 east evelyn
mountain view, CA 94041
6509382100
MDR Report Key6916142
MDR Text Key88239856
Report Number0002954917-2017-00090
Device Sequence Number1
Product Code NRY
Combination Product (y/n)N
PMA/PMN Number
K150616
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/19/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/05/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/28/2018
Device Catalogue Number90185
Device Lot Number60338
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/30/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/06/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age75 YR
-
-